SCHEMBL4138863

SCHEMBL4138863

Cc1cccc(C(=O)Nc2ccccc2)c1C

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.77
KCNK3 O14649 1/20 0.62
KCNK9 Q9NPC2 1/20 0.62
SMN1; SMN2 Q16637 2/20 0.60
ALDH1A1 P00352 4/20 0.59
TYK2 P29597 1/20 0.58
POLB P06746 2/20 0.58
GAA P10253 1/20 0.58
CRHBP P24387 1/20 0.58
FNTA P49354 1/20 0.58
FNTB P49356 1/20 0.58
CRHR2 Q13324 1/20 0.58
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
LMNA P02545 2/20 0.58
TP53 P04637 2/20 0.58
HTT P42858 2/20 0.58
HSD17B10 Q99714 2/20 0.58
KDM4E B2RXH2 1/20 0.58
FFAR1 O14842 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14688750 0.88 NPC1 (0.63) HPGDSMN1; SMN2ALDH1A1TYK2POLB
SCHEMBL21993 0.87 HPGD (1.00) HPGDKCNK3KCNK9SMN1; SMN2ALDH1A1
SCHEMBL3411986 0.86 HPGD (0.66) HPGDKCNK3KCNK9SMN1; SMN2ALDH1A1
SCHEMBL24172126 0.84 PTGS2 (0.70) HPGDKCNK3KCNK9SMN1; SMN2ALDH1A1
SCHEMBL7764478 0.84 HPGD (0.74) HPGDKCNK3KCNK9SMN1; SMN2ALDH1A1
SCHEMBL28994974 0.84 HPGD (0.74) HPGDKCNK3KCNK9SMN1; SMN2ALDH1A1
Iodomethane SCHEMBL20530190 0.84 HPGD (0.93) HPGDKCNK3KCNK9SMN1; SMN2ALDH1A1
SCHEMBL22720100 0.83 HPGD (0.72) HPGDKCNK3KCNK9SMN1; SMN2ALDH1A1
SCHEMBL18190481 0.83 MEN1 (0.72) HPGDKCNK3KCNK9SMN1; SMN2ALDH1A1
SCHEMBL28652342 0.82 HSD17B10 (0.70) HPGDALDH1A1POLBCRHBPCRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102203067-B Hedgehog pathway modulators IRM LLC 2014-01-15 CN claimed
CN-118019802-A Resin composition, prepreg, metal foil-clad laminate, resin composite sheet, printed wiring board, and semiconductor device 三菱瓦斯化学株式会社 2024-05-10 CN disclosed
CN-118019807-A Resin composition, prepreg, metal foil-clad laminate, resin composite sheet, printed wiring board, and semiconductor device 三菱瓦斯化学株式会社 2024-05-10 CN disclosed
CN-115057794-B Method for removing methylation of cerium catalytic oxidation amide by visible light induction 桂林理工大学 2023-11-17 CN disclosed
CN-110294772-B 2-alkyl silicon-benzamide compound and synthesis method thereof 五邑大学 2021-12-28 CN disclosed
CN-109942461-B Malononitrile oxime ether compound and its use 沈阳中化农药化工研发有限公司 2020-12-01 CN disclosed
CN-110015977-B Malononitrile oxime ether compound and its use 沈阳中化农药化工研发有限公司 2020-09-15 CN disclosed
US-8735384-B2 Amino heteroaryl compounds as beta-secretase modulators and methods of use AMGEN INC. (US) 2014-05-27 US disclosed
CN-102203067-B Hedgehog pathway modulators IRM LLC 2014-01-15 CN disclosed
US-20130040931-A1 Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use AMGEN INC. (US) 2013-02-14 US disclosed
US-20090131657-A1 PROCESS FOR ALKENYLATING CARBOXAMIDES BASF SE (DE) 2009-05-21 US disclosed
CN-1890240-A Diazabicyclononene derivatives and their use as renin inhibitors ACTELION PHARMACEUTICALS LTD (CH) 2007-01-03 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130040931-A1 Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use BACE1, BACE2, APH1B HPGD 2637/4885KCNK3 2955/4885KCNK9 3126/4885
US-20090131657-A1 PROCESS FOR ALKENYLATING CARBOXAMIDES PRMT5, CYC1, CBR3 HPGD 3495/4885KCNK3 1488/4885KCNK9 2932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.